Michael Soeberdt
Overview
Explore the profile of Michael Soeberdt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adam D, Arany J, Toth K, Poliska S, Varadi J, Kolozsi P, et al.
Arch Dermatol Res
. 2025 Mar;
317(1):524.
PMID: 40056258
No abstract available.
2.
Adam D, Arany J, Toth K, Poliska S, Varadi J, Kolozsi P, et al.
Arch Dermatol Res
. 2025 Jan;
317(1):277.
PMID: 39825940
We have recently shown that fluoxetine (FX) suppressed polyinosinic-polycytidylic acid-induced inflammatory response and endothelin release in human epidermal keratinocytes, via the indirect inhibition of the phosphoinositide 3-kinase (PI3K)-pathway. Because PI3K-signaling...
3.
Milosevic M, Magnutzki A, Braun T, Hussain S, Jakschitz T, Kragl M, et al.
Biomed Pharmacother
. 2024 Dec;
182():117747.
PMID: 39671726
Urinary tract infections are among the most frequently occurring forms of infection, and inflammation and tissue damage contribute significantly to symptoms, e.g., dysuria and urge. Canephron N is an orally...
4.
Neubauer C, Kragl M, Braun T, Filipek P, Bonyadi Rad E, Grander J, et al.
Eur J Dermatol
. 2024 Aug;
34(4):416-424.
PMID: 39193679
Atopic dermatitis (AD) is a highly prevalent chronic skin disease. Anti-inflammatory and antipruritic emollients (emollients plus) with excellent cosmetic properties may alleviate AD-related symptoms and reduce the number of exacerbations....
5.
Toth K, Adam D, Arany J, Ramirez Y, Biro T, Drake J, et al.
Exp Dermatol
. 2024 Jan;
33(1):e14988.
PMID: 38284184
Fluoxetine is a safe antidepressant with remarkable anti-inflammatory actions; therefore, we aimed to investigate its effects on immortalized (HaCaT) as well as primary human epidermal keratinocytes in a polyinosinic-polycytidylic acid...
6.
Marsella R, Ahrens K, Wilkes R, Soeberdt M, Abels C
Exp Dermatol
. 2021 Nov;
31(4):628-632.
PMID: 34839557
This prospective, 4-week, placebo-controlled, cross-over study aimed to investigate the efficacy of 1% topical κ-opioid agonist, asimadoline, in a model of canine atopic dermatitis (AD). Fourteen beagles were challenged with...
7.
Soeberdt M, Kilic A, Abels C
Exp Dermatol
. 2020 Jul;
29(9):801-813.
PMID: 32628803
The skin as a neuroendocrine organ and the role of neuroendocrine signalling in the development of disorders affecting the skin and its appendages has received increasing attention in the last...
8.
Cheret J, Gherardini J, Soeberdt M, Hundt J, Abels C, Bertolini M, et al.
J Dermatol
. 2020 Jun;
47(8):917-921.
PMID: 32537810
Kappa-opioid receptor (KOR) activation reportedly elicits anti-inflammatory responses and can downregulate neuropeptide release from sensory nerve fibers. While this renders KOR agonists (KORAs) potentially interesting therapeutics in skin diseases associated...
9.
Soeberdt M, Kilic A, Abels C
Eur J Pharmacol
. 2020 Jun;
881:173242.
PMID: 32504692
Chronic pruritus is a cardinal symptom of the inflammatory skin disease atopic dermatitis (AD). Pathogenic mechanisms in the periphery, spinal cord and the brain have been implicated in AD-related pruritus....
10.
Proksch E, Soeberdt M, Neumann C, Kilic A, Reich H, Abels C
Skin Pharmacol Physiol
. 2019 Sep;
32(6):328-336.
PMID: 31533120
The pH of the skin is tightly regulated by endogenous buffering systems. We examined the influence of buffers of different pH and composition on skin barrier repair, pH, inflammation, and...